

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | tyrosine metabolic process (GO:0006570) | 8.82482974 |
| 2 | * retinol metabolic process (GO:0042572) | 6.71980864 |
| 3 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 6.51294339 |
| 4 | retinoic acid metabolic process (GO:0042573) | 6.37323032 |
| 5 | rhodopsin mediated signaling pathway (GO:0016056) | 5.98951263 |
| 6 | camera-type eye morphogenesis (GO:0048593) | 5.95968350 |
| 7 | secondary metabolic process (GO:0019748) | 5.81371674 |
| 8 | mitochondrion distribution (GO:0048311) | 5.48123558 |
| 9 | phenol-containing compound biosynthetic process (GO:0046189) | 5.43418317 |
| 10 | * detection of light stimulus involved in visual perception (GO:0050908) | 5.39043623 |
| 11 | * detection of light stimulus involved in sensory perception (GO:0050962) | 5.39043623 |
| 12 | positive regulation of guanylate cyclase activity (GO:0031284) | 5.06451724 |
| 13 | * fat-soluble vitamin metabolic process (GO:0006775) | 4.97697058 |
| 14 | melanocyte differentiation (GO:0030318) | 4.91541143 |
| 15 | * cellular response to electrical stimulus (GO:0071257) | 4.70503297 |
| 16 | short-term memory (GO:0007614) | 4.59569572 |
| 17 | bicarbonate transport (GO:0015701) | 4.58872848 |
| 18 | regulation of guanylate cyclase activity (GO:0031282) | 4.53945674 |
| 19 | * phototransduction (GO:0007602) | 4.53832823 |
| 20 | pigment cell differentiation (GO:0050931) | 4.49085101 |
| 21 | diterpenoid biosynthetic process (GO:0016102) | 4.48553770 |
| 22 | ear development (GO:0043583) | 4.40206672 |
| 23 | presynaptic membrane assembly (GO:0097105) | 4.38895979 |
| 24 | * primary alcohol metabolic process (GO:0034308) | 4.28896672 |
| 25 | postsynaptic membrane organization (GO:0001941) | 4.21192685 |
| 26 | photoreceptor cell differentiation (GO:0046530) | 4.20604073 |
| 27 | eye photoreceptor cell differentiation (GO:0001754) | 4.20604073 |
| 28 | response to auditory stimulus (GO:0010996) | 4.12715284 |
| 29 | * detection of light stimulus (GO:0009583) | 4.07214383 |
| 30 | mechanosensory behavior (GO:0007638) | 3.98478876 |
| 31 | vascular smooth muscle contraction (GO:0014829) | 3.89780519 |
| 32 | cellular response to cholesterol (GO:0071397) | 3.89743038 |
| 33 | Notch signaling involved in heart development (GO:0061314) | 3.84265352 |
| 34 | positive regulation of neuroblast proliferation (GO:0002052) | 3.78506632 |
| 35 | eye photoreceptor cell development (GO:0042462) | 3.76841625 |
| 36 | photoreceptor cell development (GO:0042461) | 3.76169333 |
| 37 | cholesterol biosynthetic process (GO:0006695) | 3.74703193 |
| 38 | C4-dicarboxylate transport (GO:0015740) | 3.70238980 |
| 39 | gamma-aminobutyric acid transport (GO:0015812) | 3.69993478 |
| 40 | extracellular matrix assembly (GO:0085029) | 3.68286321 |
| 41 | ketone body metabolic process (GO:1902224) | 3.64794544 |
| 42 | retinal rod cell development (GO:0046548) | 3.64707671 |
| 43 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.62945493 |
| 44 | * phototransduction, visible light (GO:0007603) | 3.61323366 |
| 45 | * retinal metabolic process (GO:0042574) | 3.57294766 |
| 46 | presynaptic membrane organization (GO:0097090) | 3.50487047 |
| 47 | carnitine metabolic process (GO:0009437) | 3.50213719 |
| 48 | * retinoid metabolic process (GO:0001523) | 3.48334709 |
| 49 | * visual perception (GO:0007601) | 3.47546558 |
| 50 | serine family amino acid catabolic process (GO:0009071) | 3.46894815 |
| 51 | developmental pigmentation (GO:0048066) | 3.46395327 |
| 52 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 3.45235149 |
| 53 | negative regulation of stress fiber assembly (GO:0051497) | 3.43641972 |
| 54 | * sensory perception of light stimulus (GO:0050953) | 3.43393751 |
| 55 | regulation of cGMP metabolic process (GO:0030823) | 3.42409733 |
| 56 | sterol biosynthetic process (GO:0016126) | 3.40998616 |
| 57 | photoreceptor cell maintenance (GO:0045494) | 3.40890459 |
| 58 | regulation of cGMP biosynthetic process (GO:0030826) | 3.37336736 |
| 59 | keratan sulfate catabolic process (GO:0042340) | 3.36554810 |
| 60 | regulation of skeletal muscle contraction (GO:0014819) | 3.31483862 |
| 61 | modified amino acid transport (GO:0072337) | 3.26623537 |
| 62 | positive regulation of cGMP metabolic process (GO:0030825) | 3.26122360 |
| 63 | * diterpenoid metabolic process (GO:0016101) | 3.25492366 |
| 64 | nonmotile primary cilium assembly (GO:0035058) | 3.23434391 |
| 65 | negative regulation of catenin import into nucleus (GO:0035414) | 3.22076304 |
| 66 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G- | 3.21042192 |
| 67 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.19829240 |
| 68 | cell-cell junction maintenance (GO:0045217) | 3.18093251 |
| 69 | retina development in camera-type eye (GO:0060041) | 3.17560232 |
| 70 | icosanoid secretion (GO:0032309) | 3.16144147 |
| 71 | arachidonic acid secretion (GO:0050482) | 3.16144147 |
| 72 | terpenoid biosynthetic process (GO:0016114) | 3.14452492 |
| 73 | sodium-independent organic anion transport (GO:0043252) | 3.14203266 |
| 74 | response to lipoprotein particle (GO:0055094) | 3.10470118 |
| 75 | pigment biosynthetic process (GO:0046148) | 3.10301655 |
| 76 | neuroepithelial cell differentiation (GO:0060563) | 3.08651321 |
| 77 | isoprenoid biosynthetic process (GO:0008299) | 3.08561371 |
| 78 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.06953587 |
| 79 | cellular response to sterol (GO:0036315) | 3.06269560 |
| 80 | * detection of external stimulus (GO:0009581) | 3.06111984 |
| 81 | * detection of visible light (GO:0009584) | 3.06002506 |
| 82 | cysteine metabolic process (GO:0006534) | 3.04876753 |
| 83 | negative regulation of astrocyte differentiation (GO:0048712) | 3.01379042 |
| 84 | cornea development in camera-type eye (GO:0061303) | 3.01103671 |
| 85 | quaternary ammonium group transport (GO:0015697) | 3.00847917 |
| 86 | * vitamin A metabolic process (GO:0006776) | 23.1414615 |
| 87 | * detection of abiotic stimulus (GO:0009582) | 2.98393335 |
| 88 | * terpenoid metabolic process (GO:0006721) | 2.97417095 |
| 89 | embryonic viscerocranium morphogenesis (GO:0048703) | 2.97029596 |
| 90 | response to pheromone (GO:0019236) | 2.95303562 |
| 91 | chemokine-mediated signaling pathway (GO:0070098) | 2.95057656 |
| 92 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.93661988 |
| 93 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 2.92852979 |
| 94 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.91502069 |
| 95 | negative regulation of heart growth (GO:0061117) | 2.91502069 |
| 96 | somatic stem cell division (GO:0048103) | 2.90280540 |
| 97 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.88261541 |
| 98 | axon extension involved in axon guidance (GO:0048846) | 2.88261541 |
| 99 | neuron cell-cell adhesion (GO:0007158) | 2.87748691 |
| 100 | amino acid import (GO:0043090) | 2.87389621 |
| 101 | dermatan sulfate biosynthetic process (GO:0030208) | 2.86393149 |
| 102 | regulation of neurotransmitter uptake (GO:0051580) | 2.85240683 |
| 103 | chondroitin sulfate catabolic process (GO:0030207) | 2.84084579 |
| 104 | aggressive behavior (GO:0002118) | 2.83530475 |
| 105 | negative regulation of protein localization to cell surface (GO:2000009) | 2.80889816 |
| 106 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 2.80444661 |
| 107 | aromatic amino acid family metabolic process (GO:0009072) | 2.78740483 |
| 108 | L-amino acid import (GO:0043092) | 2.78532541 |
| 109 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.77432365 |
| 110 | neurotransmitter uptake (GO:0001504) | 2.76051939 |
| 111 | regulation of neuroblast proliferation (GO:1902692) | 2.75613457 |
| 112 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.75396243 |
| 113 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.74834888 |
| 114 | astrocyte differentiation (GO:0048708) | 2.70787322 |
| 115 | negative regulation of neurotransmitter transport (GO:0051589) | 2.70130111 |
| 116 | negative regulation of actin filament bundle assembly (GO:0032232) | 2.69159607 |
| 117 | L-serine metabolic process (GO:0006563) | 2.66316581 |
| 118 | icosanoid transport (GO:0071715) | 2.65548196 |
| 119 | fatty acid derivative transport (GO:1901571) | 2.65548196 |
| 120 | myelination in peripheral nervous system (GO:0022011) | 2.65430487 |
| 121 | peripheral nervous system axon ensheathment (GO:0032292) | 2.65430487 |
| 122 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.64321469 |
| 123 | branch elongation of an epithelium (GO:0060602) | 2.63702869 |
| 124 | cilium morphogenesis (GO:0060271) | 2.63211225 |
| 125 | cellular potassium ion homeostasis (GO:0030007) | 2.63175756 |
| 126 | amino-acid betaine metabolic process (GO:0006577) | 2.60869599 |
| 127 | negative regulation of vascular permeability (GO:0043116) | 2.60335609 |
| 128 | dermatan sulfate metabolic process (GO:0030205) | 2.60137916 |
| 129 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.59647568 |
| 130 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.58475716 |
| 131 | negative regulation of hormone metabolic process (GO:0032351) | 2.58475716 |
| 132 | regulation of glucocorticoid metabolic process (GO:0031943) | 2.58109939 |
| 133 | otic vesicle formation (GO:0030916) | 2.57650364 |
| 134 | neuronal ion channel clustering (GO:0045161) | 2.57428729 |
| 135 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 2.55447248 |
| 136 | acidic amino acid transport (GO:0015800) | 2.54722726 |
| 137 | extracellular fibril organization (GO:0043206) | 2.54515266 |
| 138 | cell junction maintenance (GO:0034331) | 2.53314219 |
| 139 | eye morphogenesis (GO:0048592) | 2.49284429 |
| 140 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.48816374 |
| 141 | leukotriene biosynthetic process (GO:0019370) | 2.43927632 |
| 142 | pigment metabolic process (GO:0042440) | 2.41981205 |
| 143 | * isoprenoid metabolic process (GO:0006720) | 2.40370815 |
| 144 | tonic smooth muscle contraction (GO:0014820) | 2.36641033 |
| 145 | organ formation (GO:0048645) | 2.36320701 |
| 146 | short-chain fatty acid metabolic process (GO:0046459) | 2.36040683 |
| 147 | skeletal muscle adaptation (GO:0043501) | 2.32358772 |
| 148 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.31342460 |
| 149 | axis elongation (GO:0003401) | 2.31174801 |
| 150 | mitochondrion localization (GO:0051646) | 2.30057855 |
| 151 | regulation of systemic arterial blood pressure (GO:0003073) | 2.28950612 |
| 152 | auditory behavior (GO:0031223) | 2.28125711 |
| 153 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.27405594 |
| 154 | artery smooth muscle contraction (GO:0014824) | 2.24016018 |
| 155 | collagen catabolic process (GO:0030574) | 2.18782654 |
| 156 | positive regulation of neural precursor cell proliferation (GO:2000179) | 2.17359555 |
| 157 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 2.15999313 |
| 158 | collagen metabolic process (GO:0032963) | 2.15745475 |
| 159 | regulation of steroid hormone biosynthetic process (GO:0090030) | 2.13445975 |
| 160 | negative regulation of response to reactive oxygen species (GO:1901032) | 2.13122944 |
| 161 | regulation of extracellular matrix disassembly (GO:0010715) | 2.10673005 |
| 162 | endothelial cell morphogenesis (GO:0001886) | 2.07094447 |
| 163 | layer formation in cerebral cortex (GO:0021819) | 2.05806876 |
| 164 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.05140069 |
| 165 | phenol-containing compound metabolic process (GO:0018958) | 2.04822927 |
| 166 | melanin biosynthetic process (GO:0042438) | 16.6680597 |
| 167 | melanin metabolic process (GO:0006582) | 15.2432565 |
| 168 | secondary metabolite biosynthetic process (GO:0044550) | 14.0774997 |
| 169 | protein-chromophore linkage (GO:0018298) | 13.5993313 |
| 170 | multicellular organismal catabolic process (GO:0044243) | 1.99281662 |
| 171 | columnar/cuboidal epithelial cell differentiation (GO:0002065) | 1.98727808 |
| 172 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 1.97294777 |
| 173 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 1.96854804 |
| 174 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 1.96230561 |
| 175 | pyruvate metabolic process (GO:0006090) | 1.96229771 |
| 176 | embryonic camera-type eye development (GO:0031076) | 1.95420477 |
| 177 | * cellular aldehyde metabolic process (GO:0006081) | 1.94935033 |
| 178 | morphogenesis of an epithelial fold (GO:0060571) | 1.94127481 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.22554991 |
| 2 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 3.76958027 |
| 3 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.83247914 |
| 4 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.67661478 |
| 5 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 2.59419308 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.32524540 |
| 7 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.29060619 |
| 8 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.23914457 |
| 9 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.20125879 |
| 10 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.10549733 |
| 11 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.10118056 |
| 12 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.06718295 |
| 13 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.01375400 |
| 14 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.91353751 |
| 15 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.89271384 |
| 16 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.88587195 |
| 17 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.88569998 |
| 18 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.88569998 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.87770329 |
| 20 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.83600583 |
| 21 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.80614043 |
| 22 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.80503699 |
| 23 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.78443711 |
| 24 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.77850598 |
| 25 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.77185823 |
| 26 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.73445884 |
| 27 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.72588889 |
| 28 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.67430838 |
| 29 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.65940063 |
| 30 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.65207454 |
| 31 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.65005982 |
| 32 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.62995949 |
| 33 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.62983398 |
| 34 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.61889192 |
| 35 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.57826256 |
| 36 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.55657426 |
| 37 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.54472603 |
| 38 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.52966214 |
| 39 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.48876593 |
| 40 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.45611654 |
| 41 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.44908323 |
| 42 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.44746484 |
| 43 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.44285893 |
| 44 | EWS_26573619_Chip-Seq_HEK293_Human | 1.42266752 |
| 45 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.40931875 |
| 46 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.40131506 |
| 47 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.38225357 |
| 48 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.36205523 |
| 49 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.36155488 |
| 50 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.36106279 |
| 51 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.34949758 |
| 52 | CJUN_26792858_Chip-Seq_BT549_Human | 1.32032002 |
| 53 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.31586736 |
| 54 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.30526672 |
| 55 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.29294765 |
| 56 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.29098475 |
| 57 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.27996348 |
| 58 | AR_25329375_ChIP-Seq_VCAP_Human | 1.27641456 |
| 59 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.27138169 |
| 60 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.26401879 |
| 61 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.25942631 |
| 62 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.25280824 |
| 63 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.25016159 |
| 64 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.24160992 |
| 65 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.22847630 |
| 66 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.22738005 |
| 67 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.21895582 |
| 68 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.21887971 |
| 69 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.21343964 |
| 70 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.19842083 |
| 71 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.19176682 |
| 72 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.18318668 |
| 73 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.18039940 |
| 74 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.17465381 |
| 75 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.14972329 |
| 76 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.14590520 |
| 77 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.14484434 |
| 78 | TP53_16413492_ChIP-PET_HCT116_Human | 1.13534169 |
| 79 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.12183819 |
| 80 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.12111342 |
| 81 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.11991319 |
| 82 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.11957811 |
| 83 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.11905728 |
| 84 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.10956652 |
| 85 | P300_19829295_ChIP-Seq_ESCs_Human | 1.10434203 |
| 86 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.08401232 |
| 87 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.08320205 |
| 88 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.08118243 |
| 89 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.07913757 |
| 90 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.07685713 |
| 91 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.07423010 |
| 92 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.06749001 |
| 93 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.06410315 |
| 94 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.06334003 |
| 95 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.06207570 |
| 96 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.05502880 |
| 97 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.05290209 |
| 98 | KDM2B_26808549_Chip-Seq_REH_Human | 1.04777088 |
| 99 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.03776417 |
| 100 | JUN_21703547_ChIP-Seq_K562_Human | 1.03340776 |
| 101 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.03082774 |
| 102 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.02456492 |
| 103 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.02263643 |
| 104 | * TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.01063873 |
| 105 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.00998336 |
| 106 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.00773626 |
| 107 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.00425899 |
| 108 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.99993407 |
| 109 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.97620391 |
| 110 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.97321327 |
| 111 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.97183666 |
| 112 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.95773080 |
| 113 | STAT3_23295773_ChIP-Seq_U87_Human | 0.95648003 |
| 114 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.95541038 |
| 115 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.95447483 |
| 116 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.91723333 |
| 117 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.91524145 |
| 118 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.90673764 |
| 119 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.90525331 |
| 120 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.90488957 |
| 121 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.90488957 |
| 122 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.89967448 |
| 123 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.89906092 |
| 124 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89693853 |
| 125 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.89691859 |
| 126 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.89183373 |
| 127 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.89078742 |
| 128 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.88505669 |
| 129 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.88165732 |
| 130 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.86832865 |
| 131 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.85923471 |
| 132 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.85704792 |
| 133 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.85580111 |
| 134 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.84795168 |
| 135 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84750135 |
| 136 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.84750135 |
| 137 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.84472419 |
| 138 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.84132137 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0003011_delayed_dark_adaptation | 9.89661911 |
| 2 | MP0000372_irregular_coat_pigmentation | 7.03446732 |
| 3 | MP0005257_abnormal_intraocular_pressure | 6.55137711 |
| 4 | MP0003136_yellow_coat_color | 5.80447883 |
| 5 | MP0005171_absent_coat_pigmentation | 5.38835675 |
| 6 | MP0005423_abnormal_somatic_nervous | 3.94541345 |
| 7 | MP0001986_abnormal_taste_sensitivity | 3.74415648 |
| 8 | MP0002090_abnormal_vision | 3.63518542 |
| 9 | * MP0005551_abnormal_eye_electrophysiolog | 3.49856395 |
| 10 | * MP0005253_abnormal_eye_physiology | 3.15774957 |
| 11 | MP0005408_hypopigmentation | 3.06082547 |
| 12 | MP0000371_diluted_coat_color | 3.06077433 |
| 13 | MP0005409_darkened_coat_color | 2.88141949 |
| 14 | * MP0001324_abnormal_eye_pigmentation | 2.66609109 |
| 15 | * MP0004019_abnormal_vitamin_homeostasis | 2.42789774 |
| 16 | MP0000015_abnormal_ear_pigmentation | 2.36310238 |
| 17 | MP0006072_abnormal_retinal_apoptosis | 2.16807081 |
| 18 | MP0001984_abnormal_olfaction | 1.95019474 |
| 19 | * MP0005391_vision/eye_phenotype | 1.92754925 |
| 20 | MP0004381_abnormal_hair_follicle | 1.91432432 |
| 21 | MP0002075_abnormal_coat/hair_pigmentati | 1.90045783 |
| 22 | MP0005075_abnormal_melanosome_morpholog | 1.82613369 |
| 23 | MP0008438_abnormal_cutaneous_collagen | 1.70642291 |
| 24 | MP0002095_abnormal_skin_pigmentation | 1.63138034 |
| 25 | MP0005503_abnormal_tendon_morphology | 1.58956873 |
| 26 | MP0001186_pigmentation_phenotype | 1.57666688 |
| 27 | MP0004885_abnormal_endolymph | 1.56043892 |
| 28 | MP0001879_abnormal_lymphatic_vessel | 1.51057857 |
| 29 | MP0005377_hearing/vestibular/ear_phenot | 1.50063381 |
| 30 | MP0003878_abnormal_ear_physiology | 1.50063381 |
| 31 | MP0005197_abnormal_uvea_morphology | 1.47797503 |
| 32 | MP0000566_synostosis | 1.43303486 |
| 33 | MP0005275_abnormal_skin_tensile | 1.22632765 |
| 34 | MP0000516_abnormal_urinary_system | 1.19679144 |
| 35 | MP0005367_renal/urinary_system_phenotyp | 1.19679144 |
| 36 | MP0000778_abnormal_nervous_system | 1.18951800 |
| 37 | MP0001529_abnormal_vocalization | 1.14402501 |
| 38 | MP0002877_abnormal_melanocyte_morpholog | 1.10822266 |
| 39 | * MP0005195_abnormal_posterior_eye | 1.09534992 |
| 40 | MP0001502_abnormal_circadian_rhythm | 1.09477182 |
| 41 | MP0000462_abnormal_digestive_system | 1.09409168 |
| 42 | MP0002089_abnormal_postnatal_growth/wei | 1.09128057 |
| 43 | MP0004272_abnormal_basement_membrane | 1.06154281 |
| 44 | MP0000534_abnormal_ureter_morphology | 1.04539498 |
| 45 | MP0005248_abnormal_Harderian_gland | 1.03250974 |
| 46 | MP0005193_abnormal_anterior_eye | 1.00631398 |
| 47 | MP0009384_cardiac_valve_regurgitation | 0.99823920 |
| 48 | MP0004043_abnormal_pH_regulation | 0.98314539 |
| 49 | MP0002249_abnormal_larynx_morphology | 0.91814285 |
| 50 | * MP0002092_abnormal_eye_morphology | 0.84949950 |
| 51 | MP0002102_abnormal_ear_morphology | 0.84049592 |
| 52 | MP0008789_abnormal_olfactory_epithelium | 0.83122934 |
| 53 | MP0003942_abnormal_urinary_system | 0.79621894 |
| 54 | MP0010030_abnormal_orbit_morphology | 0.78177025 |
| 55 | MP0002653_abnormal_ependyma_morphology | 0.77751170 |
| 56 | MP0002938_white_spotting | 0.76260823 |
| 57 | MP0000920_abnormal_myelination | 0.74598282 |
| 58 | MP0005167_abnormal_blood-brain_barrier | 0.74314000 |
| 59 | MP0000579_abnormal_nail_morphology | 0.72225298 |
| 60 | MP0002282_abnormal_trachea_morphology | 0.72155465 |
| 61 | MP0006054_spinal_hemorrhage | 0.71068644 |
| 62 | MP0003690_abnormal_glial_cell | 0.69919440 |
| 63 | MP0000026_abnormal_inner_ear | 0.68751668 |
| 64 | MP0001764_abnormal_homeostasis | 0.68585371 |
| 65 | MP0004859_abnormal_synaptic_plasticity | 0.68382647 |
| 66 | MP0002822_catalepsy | 0.68014014 |
| 67 | MP0000762_abnormal_tongue_morphology | 0.67678019 |
| 68 | MP0005394_taste/olfaction_phenotype | 0.67190715 |
| 69 | MP0005499_abnormal_olfactory_system | 0.67190715 |
| 70 | MP0002572_abnormal_emotion/affect_behav | 0.67127793 |
| 71 | MP0003705_abnormal_hypodermis_morpholog | 0.66748835 |
| 72 | MP0002295_abnormal_pulmonary_circulatio | 0.65308574 |
| 73 | MP0001286_abnormal_eye_development | 0.64976108 |
| 74 | MP0002638_abnormal_pupillary_reflex | 0.64189117 |
| 75 | MP0005187_abnormal_penis_morphology | 0.64040043 |
| 76 | MP0000049_abnormal_middle_ear | 0.59476031 |
| 77 | MP0010234_abnormal_vibrissa_follicle | 0.59303778 |
| 78 | MP0002063_abnormal_learning/memory/cond | 0.58659254 |
| 79 | MP0005595_abnormal_vascular_smooth | 0.57776440 |
| 80 | MP0000751_myopathy | 0.57293824 |
| 81 | MP0004270_analgesia | 0.57138076 |
| 82 | MP0004130_abnormal_muscle_cell | 0.56937528 |
| 83 | MP0000569_abnormal_digit_pigmentation | 0.56809321 |
| 84 | MP0004036_abnormal_muscle_relaxation | 0.56616538 |
| 85 | MP0003631_nervous_system_phenotype | 0.56567837 |
| 86 | MP0000537_abnormal_urethra_morphology | 0.56165791 |
| 87 | MP0003755_abnormal_palate_morphology | 0.55989257 |
| 88 | MP0004142_abnormal_muscle_tone | 0.55654617 |
| 89 | MP0003938_abnormal_ear_development | 0.54378657 |
| 90 | MP0002233_abnormal_nose_morphology | 0.54042974 |
| 91 | MP0000631_abnormal_neuroendocrine_gland | 0.53752761 |
| 92 | MP0005360_urolithiasis | 0.53354196 |
| 93 | MP0000013_abnormal_adipose_tissue | 0.53272735 |
| 94 | MP0002697_abnormal_eye_size | 0.53145453 |
| 95 | MP0001293_anophthalmia | 0.52278344 |
| 96 | MP0001968_abnormal_touch/_nociception | 0.50951655 |
| 97 | MP0002067_abnormal_sensory_capabilities | 0.49960077 |
| 98 | MP0002127_abnormal_cardiovascular_syste | 0.49804350 |
| 99 | MP0010329_abnormal_lipoprotein_level | 0.49273177 |
| 100 | MP0004858_abnormal_nervous_system | 0.48668235 |
| 101 | MP0010678_abnormal_skin_adnexa | 0.47827146 |
| 102 | MP0000647_abnormal_sebaceous_gland | 0.47782414 |
| 103 | MP0001270_distended_abdomen | 0.47411431 |
| 104 | MP0002736_abnormal_nociception_after | 0.47203224 |
| 105 | MP0001177_atelectasis | 0.47118553 |
| 106 | MP0002272_abnormal_nervous_system | 0.46787315 |
| 107 | MP0001299_abnormal_eye_distance/ | 0.46768121 |
| 108 | MP0002108_abnormal_muscle_morphology | 0.46473752 |
| 109 | MP0001963_abnormal_hearing_physiology | 0.46173687 |
| 110 | MP0009250_abnormal_appendicular_skeleto | 0.45879969 |
| 111 | MP0003283_abnormal_digestive_organ | 0.45246688 |
| 112 | MP0008961_abnormal_basal_metabolism | 0.45109752 |
| 113 | MP0003937_abnormal_limbs/digits/tail_de | 0.44617135 |
| 114 | MP0005623_abnormal_meninges_morphology | 0.44276154 |
| 115 | MP0002734_abnormal_mechanical_nocicepti | 0.43718911 |
| 116 | MP0003329_amyloid_beta_deposits | 0.43467098 |
| 117 | MP0003300_gastrointestinal_ulcer | 0.43080239 |
| 118 | MP0003385_abnormal_body_wall | 0.42097333 |
| 119 | * MP0002752_abnormal_somatic_nervous | 0.41916633 |
| 120 | MP0000428_abnormal_craniofacial_morphol | 0.40785865 |
| 121 | MP0000955_abnormal_spinal_cord | 0.40221167 |
| 122 | MP0000367_abnormal_coat/_hair | 0.38930969 |
| 123 | MP0003075_altered_response_to | 0.38872293 |
| 124 | MP0000767_abnormal_smooth_muscle | 0.38345788 |
| 125 | MP0004084_abnormal_cardiac_muscle | 0.37495983 |
| 126 | MP0009697_abnormal_copulation | 0.37489384 |
| 127 | MP0003279_aneurysm | 0.37341688 |
| 128 | MP0002332_abnormal_exercise_endurance | 0.35701308 |
| 129 | MP0002177_abnormal_outer_ear | 0.35302708 |
| 130 | MP0000467_abnormal_esophagus_morphology | 0.34753485 |
| 131 | MP0001486_abnormal_startle_reflex | 0.34712516 |
| 132 | MP0001346_abnormal_lacrimal_gland | 0.33108367 |
| 133 | MP0003941_abnormal_skin_development | 0.31974111 |
| 134 | MP0003453_abnormal_keratinocyte_physiol | 0.31676839 |
| 135 | MP0009780_abnormal_chondrocyte_physiolo | 0.29721307 |
| 136 | MP0010368_abnormal_lymphatic_system | 0.29509428 |
| 137 | MP0009840_abnormal_foam_cell | 0.28453144 |
| 138 | MP0005620_abnormal_muscle_contractility | 0.28365664 |
| 139 | MP0002133_abnormal_respiratory_system | 0.27912562 |
| 140 | MP0005388_respiratory_system_phenotype | 0.27912562 |
| 141 | MP0003634_abnormal_glial_cell | 0.27094034 |
| 142 | MP0000747_muscle_weakness | 0.26845683 |
| 143 | * MP0002882_abnormal_neuron_morphology | 0.26796814 |
| 144 | MP0003635_abnormal_synaptic_transmissio | 0.26297935 |
| 145 | MP0005508_abnormal_skeleton_morphology | 0.25988918 |
| 146 | MP0000383_abnormal_hair_follicle | 0.25282384 |
| 147 | MP0000465_gastrointestinal_hemorrhage | 0.25120435 |
| 148 | MP0008569_lethality_at_weaning | 0.25014356 |
| 149 | MP0001958_emphysema | 0.25013710 |
| 150 | MP0003633_abnormal_nervous_system | 0.23987333 |
| 151 | * MP0002229_neurodegeneration | 0.22654765 |
| 152 | MP0008875_abnormal_xenobiotic_pharmacok | 0.22483799 |
| 153 | MP0005166_decreased_susceptibility_to | 0.22187006 |
| 154 | MP0003115_abnormal_respiratory_system | 0.21926185 |
| 155 | MP0004215_abnormal_myocardial_fiber | 0.21903595 |
| 156 | MP0009046_muscle_twitch | 0.20984569 |
| 157 | MP0004484_altered_response_of | 0.19345389 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoplasia of the fovea (HP:0007750) | 8.80682117 |
| 2 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 8.80682117 |
| 3 | * Attenuation of retinal blood vessels (HP:0007843) | 7.84159807 |
| 4 | Constricted visual fields (HP:0001133) | 7.65909360 |
| 5 | Choroideremia (HP:0001139) | 7.06513393 |
| 6 | Aplasia/Hypoplasia of the macula (HP:0008059) | 6.79958061 |
| 7 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 6.32709449 |
| 8 | Ulnar claw (HP:0001178) | 6.31919200 |
| 9 | Blue irides (HP:0000635) | 6.24201099 |
| 10 | Action tremor (HP:0002345) | 5.94962500 |
| 11 | Bony spicule pigmentary retinopathy (HP:0007737) | 5.52714944 |
| 12 | Abolished electroretinogram (ERG) (HP:0000550) | 5.33507534 |
| 13 | Nonprogressive disorder (HP:0003680) | 5.27640226 |
| 14 | Abnormal rod and cone electroretinograms (HP:0008323) | 5.23876373 |
| 15 | Scotoma (HP:0000575) | 4.59007417 |
| 16 | Peripheral hypomyelination (HP:0007182) | 4.53219306 |
| 17 | Insidious onset (HP:0003587) | 4.48632666 |
| 18 | Termporal pattern (HP:0011008) | 4.48632666 |
| 19 | Ocular albinism (HP:0001107) | 4.40318221 |
| 20 | Segmental peripheral demyelination/remyelination (HP:0003481) | 4.09517947 |
| 21 | Iris hypopigmentation (HP:0007730) | 3.90839332 |
| 22 | Abnormal pupillary function (HP:0007686) | 3.89394886 |
| 23 | Corneal dystrophy (HP:0001131) | 3.88496609 |
| 24 | Split foot (HP:0001839) | 3.73594770 |
| 25 | Dyschromatopsia (HP:0007641) | 3.57421409 |
| 26 | Upper limb muscle weakness (HP:0003484) | 3.42618679 |
| 27 | Postural tremor (HP:0002174) | 3.31649971 |
| 28 | Congenital stationary night blindness (HP:0007642) | 3.28447415 |
| 29 | Progressive sensorineural hearing impairment (HP:0000408) | 3.13035198 |
| 30 | Increased CSF protein (HP:0002922) | 2.97864300 |
| 31 | Impaired proprioception (HP:0010831) | 2.90416989 |
| 32 | Systemic lupus erythematosus (HP:0002725) | 2.87538869 |
| 33 | * Type II diabetes mellitus (HP:0005978) | 2.86168658 |
| 34 | Pulmonary artery stenosis (HP:0004415) | 2.79916089 |
| 35 | Generalized hypopigmentation of hair (HP:0011358) | 2.76098505 |
| 36 | * Photophobia (HP:0000613) | 2.67642520 |
| 37 | Freckling (HP:0001480) | 2.65007176 |
| 38 | Macular degeneration (HP:0000608) | 2.58388839 |
| 39 | Short tibia (HP:0005736) | 2.49124049 |
| 40 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 2.45345818 |
| 41 | Hemiplegia (HP:0002301) | 2.35090244 |
| 42 | White forelock (HP:0002211) | 2.32728835 |
| 43 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.32002396 |
| 44 | Type 1 muscle fiber predominance (HP:0003803) | 2.28075145 |
| 45 | Hepatoblastoma (HP:0002884) | 2.24044811 |
| 46 | Steppage gait (HP:0003376) | 2.23689164 |
| 47 | Hammertoe (HP:0001765) | 2.19488971 |
| 48 | Nephrogenic diabetes insipidus (HP:0009806) | 2.18892580 |
| 49 | * Decreased central vision (HP:0007663) | 2.18240884 |
| 50 | Round ear (HP:0100830) | 2.16841210 |
| 51 | Gait imbalance (HP:0002141) | 2.14952348 |
| 52 | Exercise-induced muscle cramps (HP:0003710) | 2.13992029 |
| 53 | Broad metatarsal (HP:0001783) | 2.13517002 |
| 54 | Protrusio acetabuli (HP:0003179) | 2.12018899 |
| 55 | Congenital primary aphakia (HP:0007707) | 2.11747587 |
| 56 | Medial flaring of the eyebrow (HP:0010747) | 2.11600358 |
| 57 | Aplasia/Hypoplasia of the lens (HP:0008063) | 2.09809683 |
| 58 | True hermaphroditism (HP:0010459) | 2.03403907 |
| 59 | Hyperglycinuria (HP:0003108) | 2.01719457 |
| 60 | * Decreased electroretinogram (ERG) amplitude (HP:0000654) | 14.7346938 |
| 61 | Hypopigmentation of the fundus (HP:0007894) | 12.9550750 |
| 62 | Abnormality of the fovea (HP:0000493) | 12.4960640 |
| 63 | Patchy hypopigmentation of hair (HP:0011365) | 1.99480440 |
| 64 | Genital tract atresia (HP:0001827) | 1.97688818 |
| 65 | Vaginal atresia (HP:0000148) | 1.93675806 |
| 66 | Hypoplasia of the iris (HP:0007676) | 1.90609995 |
| 67 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.89359501 |
| 68 | Flat cornea (HP:0007720) | 1.89309556 |
| 69 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.88782619 |
| 70 | Distal arthrogryposis (HP:0005684) | 1.87843212 |
| 71 | Central scotoma (HP:0000603) | 1.87808132 |
| 72 | Pendular nystagmus (HP:0012043) | 1.85523214 |
| 73 | Hyperglycinemia (HP:0002154) | 1.85301301 |
| 74 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.84470207 |
| 75 | Pancreatic fibrosis (HP:0100732) | 1.84224739 |
| 76 | Complement deficiency (HP:0004431) | 1.83685098 |
| 77 | Sensorimotor neuropathy (HP:0007141) | 1.79515990 |
| 78 | Abnormality of glycine metabolism (HP:0010895) | 1.76625802 |
| 79 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.76625802 |
| 80 | Abnormality of midbrain morphology (HP:0002418) | 1.73584533 |
| 81 | Molar tooth sign on MRI (HP:0002419) | 1.73584533 |
| 82 | Generalized hypopigmentation (HP:0007513) | 1.73528140 |
| 83 | Postaxial foot polydactyly (HP:0001830) | 1.72851127 |
| 84 | Chorioretinal atrophy (HP:0000533) | 1.72826970 |
| 85 | Progressive hearing impairment (HP:0001730) | 1.72637528 |
| 86 | Renal dysplasia (HP:0000110) | 1.70861792 |
| 87 | Polyphagia (HP:0002591) | 1.70739780 |
| 88 | Peripheral demyelination (HP:0011096) | 1.69789614 |
| 89 | Abnormal auditory evoked potentials (HP:0006958) | 1.68479977 |
| 90 | Decreased lacrimation (HP:0000633) | 1.67352573 |
| 91 | Postaxial hand polydactyly (HP:0001162) | 1.66504472 |
| 92 | Aortic dissection (HP:0002647) | 1.62247155 |
| 93 | Alacrima (HP:0000522) | 1.61938202 |
| 94 | Vertebral compression fractures (HP:0002953) | 1.59898302 |
| 95 | Glomerulonephritis (HP:0000099) | 1.59711983 |
| 96 | Foot dorsiflexor weakness (HP:0009027) | 1.59177785 |
| 97 | Posterior subcapsular cataract (HP:0007787) | 1.58193813 |
| 98 | Hypermetropia (HP:0000540) | 1.57824691 |
| 99 | Absent frontal sinuses (HP:0002688) | 1.57798005 |
| 100 | Hypoalphalipoproteinemia (HP:0003233) | 1.57274537 |
| 101 | Neurofibrillary tangles (HP:0002185) | 1.56245101 |
| 102 | Nemaline bodies (HP:0003798) | 1.54945971 |
| 103 | Diplopia (HP:0000651) | 1.54929807 |
| 104 | Abnormality of binocular vision (HP:0011514) | 1.54929807 |
| 105 | Microglossia (HP:0000171) | 1.54615747 |
| 106 | Retinal atrophy (HP:0001105) | 1.53825343 |
| 107 | Absent toe (HP:0010760) | 1.53158368 |
| 108 | Occipital encephalocele (HP:0002085) | 1.53091146 |
| 109 | Cortical dysplasia (HP:0002539) | 1.52587718 |
| 110 | Abnormality of the foot musculature (HP:0001436) | 1.52057254 |
| 111 | Muscle fiber inclusion bodies (HP:0100299) | 1.51274317 |
| 112 | Abnormality of the labia minora (HP:0012880) | 1.49893074 |
| 113 | Coronal craniosynostosis (HP:0004440) | 1.48930534 |
| 114 | Preaxial foot polydactyly (HP:0001841) | 1.48123995 |
| 115 | Bronchomalacia (HP:0002780) | 1.48108883 |
| 116 | Calcaneovalgus deformity (HP:0001848) | 1.47728145 |
| 117 | Abnormality of the anterior chamber (HP:0000593) | 1.47025710 |
| 118 | Cerebral aneurysm (HP:0004944) | 1.46957423 |
| 119 | Pigmentary retinal degeneration (HP:0001146) | 1.44637613 |
| 120 | * Wide nasal bridge (HP:0000431) | 1.43202508 |
| 121 | Intrahepatic cholestasis (HP:0001406) | 1.41647485 |
| 122 | Heterochromia iridis (HP:0001100) | 1.40933395 |
| 123 | Exercise-induced myalgia (HP:0003738) | 1.39909069 |
| 124 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.34028456 |
| 125 | Cerebral inclusion bodies (HP:0100314) | 1.30510429 |
| 126 | Hyperlipoproteinemia (HP:0010980) | 1.27882384 |
| 127 | Absent phalangeal crease (HP:0006109) | 1.27335649 |
| 128 | Annular pancreas (HP:0001734) | 1.27151067 |
| 129 | Premature rupture of membranes (HP:0001788) | 1.26921196 |
| 130 | Deformed tarsal bones (HP:0008119) | 1.26679568 |
| 131 | Aortic aneurysm (HP:0004942) | 1.26611290 |
| 132 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.25614683 |
| 133 | Aplasia of the phalanges of the hand (HP:0009802) | 1.25614683 |
| 134 | Aplasia involving bones of the extremities (HP:0009825) | 1.25614683 |
| 135 | Optic disc pallor (HP:0000543) | 1.24895797 |
| 136 | Right ventricular cardiomyopathy (HP:0011663) | 1.21411950 |
| 137 | Shallow orbits (HP:0000586) | 1.20844741 |
| 138 | Abnormality of macular pigmentation (HP:0008002) | 1.19440716 |
| 139 | Slender build (HP:0001533) | 1.19369027 |
| 140 | Hemiparesis (HP:0001269) | 1.19269369 |
| 141 | Hypoventilation (HP:0002791) | 1.16394289 |
| 142 | Cone-rod dystrophy (HP:0000548) | 1.16331195 |
| 143 | Ulnar deviation of the wrist (HP:0003049) | 1.16020314 |
| 144 | Arterial tortuosity (HP:0005116) | 1.15154317 |
| 145 | Increased variability in muscle fiber diameter (HP:0003557) | 1.14884722 |
| 146 | Pallor (HP:0000980) | 1.13841544 |
| 147 | Melanoma (HP:0002861) | 1.12375606 |
| 148 | Striae distensae (HP:0001065) | 1.11786744 |
| 149 | Focal motor seizures (HP:0011153) | 1.11538770 |
| 150 | Cutaneous melanoma (HP:0012056) | 1.11478915 |
| 151 | Vascular tortuosity (HP:0004948) | 1.11335677 |
| 152 | Retinitis pigmentosa (HP:0000510) | 1.11289545 |
| 153 | Hypoglycemic seizures (HP:0002173) | 1.11136141 |
| 154 | Xanthomatosis (HP:0000991) | 1.10959182 |
| 155 | Tarsal synostosis (HP:0008368) | 1.07907791 |
| 156 | Abnormal finger flexion creases (HP:0006143) | 1.07808841 |
| 157 | Subacute progressive viral hepatitis (HP:0006572) | 1.05847375 |
| 158 | * Keratoconus (HP:0000563) | 1.05402138 |
| 159 | * Increased corneal curvature (HP:0100692) | 1.05402138 |
| 160 | Mitral valve prolapse (HP:0001634) | 1.05239571 |
| 161 | Amyloidosis (HP:0011034) | 1.04986920 |
| 162 | Congenital sensorineural hearing impairment (HP:0008527) | 1.04507875 |
| 163 | Frequent falls (HP:0002359) | 1.03810031 |
| 164 | Atrophic scars (HP:0001075) | 1.03226001 |
| 165 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.02087583 |
| 166 | Megalencephaly (HP:0001355) | 1.00945658 |
| 167 | Cardiovascular calcification (HP:0011915) | 0.98420105 |
| 168 | Difficulty running (HP:0009046) | 0.97948764 |
| 169 | Abnormality of skeletal muscle fiber size (HP:0012084) | 0.97756740 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 5.04124442 |
| 2 | CASK | 4.98638426 |
| 3 | EPHA3 | 4.13098055 |
| 4 | MST1R | 3.72667180 |
| 5 | PKN2 | 3.33395569 |
| 6 | MST4 | 2.77508931 |
| 7 | LATS1 | 2.67912570 |
| 8 | EPHA4 | 2.60688793 |
| 9 | PDK2 | 2.57326853 |
| 10 | BCKDK | 2.56881415 |
| 11 | FGFR2 | 2.43310168 |
| 12 | PBK | 2.36470647 |
| 13 | DDR2 | 2.26423372 |
| 14 | FRK | 2.11771346 |
| 15 | MET | 2.09123019 |
| 16 | PRKD3 | 2.04821583 |
| 17 | TTN | 2.04033848 |
| 18 | NEK9 | 1.77236065 |
| 19 | FLT3 | 1.73842515 |
| 20 | BMPR1B | 1.65662070 |
| 21 | PIK3CG | 1.63700247 |
| 22 | WNK4 | 1.54572833 |
| 23 | TRIB3 | 1.51769767 |
| 24 | STK38L | 1.50300599 |
| 25 | PHKG1 | 1.50188339 |
| 26 | PHKG2 | 1.50188339 |
| 27 | TGFBR2 | 1.45230466 |
| 28 | BCR | 1.45194441 |
| 29 | BMX | 1.38796938 |
| 30 | PTK6 | 1.38326873 |
| 31 | PLK2 | 1.38213490 |
| 32 | SIK1 | 1.38213015 |
| 33 | MARK3 | 1.36924141 |
| 34 | TGFBR1 | 1.36823740 |
| 35 | MUSK | 1.35249754 |
| 36 | CCNB1 | 1.34005730 |
| 37 | STK24 | 1.32256748 |
| 38 | GRK1 | 1.31888214 |
| 39 | LMTK2 | 1.31566543 |
| 40 | NTRK1 | 1.29402738 |
| 41 | TIE1 | 1.25274142 |
| 42 | PRKCH | 1.24704607 |
| 43 | PDGFRA | 1.16984866 |
| 44 | NTRK3 | 1.16760090 |
| 45 | ERBB3 | 1.11574237 |
| 46 | CSNK1G2 | 1.10921316 |
| 47 | STK39 | 1.10201621 |
| 48 | PTK2B | 1.08918775 |
| 49 | RIPK1 | 1.08558373 |
| 50 | CSNK1G1 | 1.07055884 |
| 51 | MAP3K4 | 1.01272020 |
| 52 | LRRK2 | 1.00039859 |
| 53 | CSNK1A1L | 0.98732338 |
| 54 | RET | 0.97767409 |
| 55 | PDK1 | 0.97398422 |
| 56 | IRAK1 | 0.95025713 |
| 57 | MAPK13 | 0.94495003 |
| 58 | MAPK12 | 0.91679813 |
| 59 | OXSR1 | 0.88846543 |
| 60 | MAP2K7 | 0.87732159 |
| 61 | WNK3 | 0.87318794 |
| 62 | PIK3CA | 0.86965525 |
| 63 | GSK3A | 0.86688497 |
| 64 | CSNK1G3 | 0.86345019 |
| 65 | MINK1 | 0.85836861 |
| 66 | PIM2 | 0.85803996 |
| 67 | STK3 | 0.83931070 |
| 68 | PDPK1 | 0.79425655 |
| 69 | MAP3K7 | 0.77624304 |
| 70 | EPHB1 | 0.75912464 |
| 71 | PRKD2 | 0.75862870 |
| 72 | RIPK4 | 0.75797134 |
| 73 | PKN1 | 0.74211448 |
| 74 | EIF2AK1 | 0.74125459 |
| 75 | MYLK | 0.73376062 |
| 76 | MAP3K9 | 0.71897210 |
| 77 | PAK3 | 0.71501287 |
| 78 | MAP3K2 | 0.68710208 |
| 79 | CSNK1D | 0.68634436 |
| 80 | TNIK | 0.68321803 |
| 81 | PINK1 | 0.67872956 |
| 82 | PDGFRB | 0.67567437 |
| 83 | SCYL2 | 0.67282281 |
| 84 | ERBB4 | 0.66937988 |
| 85 | MAPK7 | 0.65859505 |
| 86 | PDK3 | 0.65204068 |
| 87 | PDK4 | 0.65204068 |
| 88 | MAP3K13 | 0.64994196 |
| 89 | MOS | 0.64553633 |
| 90 | DYRK1A | 0.63946129 |
| 91 | PRKCE | 0.63655613 |
| 92 | DYRK2 | 0.63553920 |
| 93 | CDK5 | 0.62651330 |
| 94 | ROCK2 | 0.60184646 |
| 95 | FGR | 0.59059355 |
| 96 | MKNK2 | 0.59021856 |
| 97 | NTRK2 | 0.58676714 |
| 98 | CAMK2D | 0.57795931 |
| 99 | EIF2AK3 | 0.57201048 |
| 100 | ERBB2 | 0.56194016 |
| 101 | PRKD1 | 0.56161257 |
| 102 | ADRBK1 | 0.55635670 |
| 103 | AKT2 | 0.54783733 |
| 104 | PRKCG | 0.53349295 |
| 105 | JAK1 | 0.53260848 |
| 106 | LIMK1 | 0.52800236 |
| 107 | BMPR2 | 0.52681239 |
| 108 | NEK6 | 0.52498057 |
| 109 | PAK2 | 0.51609019 |
| 110 | UHMK1 | 0.51135571 |
| 111 | INSRR | 0.50213428 |
| 112 | CAMK2G | 0.49493837 |
| 113 | PRKCQ | 0.48448025 |
| 114 | NLK | 0.48117346 |
| 115 | PAK6 | 0.47983756 |
| 116 | MARK1 | 0.46589096 |
| 117 | CAMK2B | 0.44706688 |
| 118 | LATS2 | 0.44671591 |
| 119 | FGFR1 | 0.44665338 |
| 120 | CAMKK1 | 0.43813486 |
| 121 | HIPK2 | 0.43674709 |
| 122 | MAPK15 | 0.43560595 |
| 123 | CDK8 | 0.42882892 |
| 124 | FYN | 0.42874010 |
| 125 | DMPK | 0.42559492 |
| 126 | SRC | 0.42378593 |
| 127 | SGK494 | 0.41930472 |
| 128 | SGK223 | 0.41930472 |
| 129 | EGFR | 0.41803149 |
| 130 | JAK2 | 0.41514206 |
| 131 | IRAK3 | 0.38403608 |
| 132 | INSR | 0.38319283 |
| 133 | WEE1 | 0.37935705 |
| 134 | RPS6KA4 | 0.37435271 |
| 135 | IGF1R | 0.35953426 |
| 136 | EPHB2 | 0.35573031 |
| 137 | FER | 0.35311226 |
| 138 | MAPKAPK5 | 0.35012918 |
| 139 | MAP4K2 | 0.34615524 |
| 140 | CAMK1 | 0.33489390 |
| 141 | CAMK2A | 0.32346169 |
| 142 | NUAK1 | 0.31808251 |
| 143 | MAP2K4 | 0.31309573 |
| 144 | ROCK1 | 0.30372466 |
| 145 | PRKCB | 0.30072205 |
| 146 | PRKACA | 0.29937880 |
| 147 | CDC42BPA | 0.29513232 |
| 148 | SGK2 | 0.28437610 |
| 149 | CSNK1A1 | 0.26056544 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Tyrosine metabolism_Homo sapiens_hsa00350 | 4.91543889 |
| 2 | * Retinol metabolism_Homo sapiens_hsa00830 | 4.08720059 |
| 3 | Phototransduction_Homo sapiens_hsa04744 | 3.97573449 |
| 4 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 3.72846259 |
| 5 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 3.69925815 |
| 6 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.68513330 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.65086190 |
| 8 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.33245621 |
| 9 | Melanogenesis_Homo sapiens_hsa04916 | 2.05824427 |
| 10 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.92815927 |
| 11 | Bile secretion_Homo sapiens_hsa04976 | 1.85321453 |
| 12 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.74607802 |
| 13 | Histidine metabolism_Homo sapiens_hsa00340 | 1.70000493 |
| 14 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.69952089 |
| 15 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.65562134 |
| 16 | Olfactory transduction_Homo sapiens_hsa04740 | 1.56021198 |
| 17 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.50676222 |
| 18 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.48663830 |
| 19 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.42885509 |
| 20 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.38017681 |
| 21 | Salivary secretion_Homo sapiens_hsa04970 | 1.36736097 |
| 22 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.33046399 |
| 23 | Peroxisome_Homo sapiens_hsa04146 | 1.32763814 |
| 24 | Protein export_Homo sapiens_hsa03060 | 1.31031972 |
| 25 | Tight junction_Homo sapiens_hsa04530 | 1.26761959 |
| 26 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.21102452 |
| 27 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.18298878 |
| 28 | Renin secretion_Homo sapiens_hsa04924 | 1.13872579 |
| 29 | Circadian rhythm_Homo sapiens_hsa04710 | 1.13718705 |
| 30 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.12412815 |
| 31 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.10255140 |
| 32 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.09981300 |
| 33 | Circadian entrainment_Homo sapiens_hsa04713 | 1.03286053 |
| 34 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.01621396 |
| 35 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.99478054 |
| 36 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.97595198 |
| 37 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.97401154 |
| 38 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.96105794 |
| 39 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.90815770 |
| 40 | Long-term potentiation_Homo sapiens_hsa04720 | 0.90235229 |
| 41 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.88478463 |
| 42 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.88213070 |
| 43 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.87479866 |
| 44 | Glioma_Homo sapiens_hsa05214 | 0.87428555 |
| 45 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.86269545 |
| 46 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.83829968 |
| 47 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.83688801 |
| 48 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.81978582 |
| 49 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.80919386 |
| 50 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.78766385 |
| 51 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.77712121 |
| 52 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.77297032 |
| 53 | GABAergic synapse_Homo sapiens_hsa04727 | 0.76859814 |
| 54 | Sulfur relay system_Homo sapiens_hsa04122 | 0.73341706 |
| 55 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.72022441 |
| 56 | Focal adhesion_Homo sapiens_hsa04510 | 0.71034886 |
| 57 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.70787556 |
| 58 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.70480648 |
| 59 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.69556202 |
| 60 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.68062441 |
| 61 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.67512246 |
| 62 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.67088283 |
| 63 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.66592940 |
| 64 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.66305015 |
| 65 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.65825447 |
| 66 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.65732632 |
| 67 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.65321767 |
| 68 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.62988818 |
| 69 | Taste transduction_Homo sapiens_hsa04742 | 0.62198872 |
| 70 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.61709876 |
| 71 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.61136629 |
| 72 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.61127149 |
| 73 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.61085656 |
| 74 | Axon guidance_Homo sapiens_hsa04360 | 0.59812430 |
| 75 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.58925547 |
| 76 | Gap junction_Homo sapiens_hsa04540 | 0.58889311 |
| 77 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.58359979 |
| 78 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.58078772 |
| 79 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.57770081 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.56864341 |
| 81 | Amoebiasis_Homo sapiens_hsa05146 | 0.56863898 |
| 82 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.56550344 |
| 83 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.56469160 |
| 84 | ABC transporters_Homo sapiens_hsa02010 | 0.56350467 |
| 85 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.56198495 |
| 86 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.56148618 |
| 87 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.56132900 |
| 88 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.55522401 |
| 89 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.55430131 |
| 90 | Malaria_Homo sapiens_hsa05144 | 0.55098328 |
| 91 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.54465634 |
| 92 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.54250748 |
| 93 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.53866187 |
| 94 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.53644751 |
| 95 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.53442950 |
| 96 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.52796541 |
| 97 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.52674428 |
| 98 | Morphine addiction_Homo sapiens_hsa05032 | 0.52530042 |
| 99 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.52501652 |
| 100 | Parkinsons disease_Homo sapiens_hsa05012 | 0.49882654 |
| 101 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.49615377 |
| 102 | Adherens junction_Homo sapiens_hsa04520 | 0.49477984 |
| 103 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.49268936 |
| 104 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.49186163 |
| 105 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.49160700 |
| 106 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.49132485 |
| 107 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.48860149 |
| 108 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.48379607 |
| 109 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.48033341 |
| 110 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.47321235 |
| 111 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.47195196 |
| 112 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.46961251 |
| 113 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.45712248 |
| 114 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.44527312 |
| 115 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.44319765 |
| 116 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.43900568 |
| 117 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.43462940 |
| 118 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.42850755 |
| 119 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.42448277 |
| 120 | Pertussis_Homo sapiens_hsa05133 | 0.42296050 |
| 121 | Huntingtons disease_Homo sapiens_hsa05016 | 0.41871662 |
| 122 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.41751152 |
| 123 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.41746123 |
| 124 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.41486569 |
| 125 | Insulin secretion_Homo sapiens_hsa04911 | 0.40555942 |
| 126 | Cocaine addiction_Homo sapiens_hsa05030 | 0.39560741 |
| 127 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.39454440 |
| 128 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.38605069 |
| 129 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.38458335 |
| 130 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.38350214 |
| 131 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.38344161 |
| 132 | Alzheimers disease_Homo sapiens_hsa05010 | 0.36959538 |
| 133 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.34969251 |
| 134 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.34641344 |
| 135 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.34624075 |
| 136 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.34386046 |
| 137 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.34222287 |
| 138 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.33813762 |
| 139 | Prion diseases_Homo sapiens_hsa05020 | 0.31247740 |
| 140 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.30712736 |
| 141 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.30635066 |
| 142 | Metabolic pathways_Homo sapiens_hsa01100 | 0.30254434 |
| 143 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.29945289 |
| 144 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.29668703 |
| 145 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.29117335 |
| 146 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.28526473 |
| 147 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.28468039 |
| 148 | Nicotine addiction_Homo sapiens_hsa05033 | 0.27406186 |
| 149 | Carbon metabolism_Homo sapiens_hsa01200 | 0.27311090 |

